MedPage Today May 8, 2024
Shannon Firth

— Commissioner also detailed plans for “largest reorganization” in agency’s history

FDA Commissioner Robert Califf, MD, described his agency’s role in helping to prevent a wider outbreak of H5N1 avian influenza during a hearing of the Senate Appropriations Committee on Wednesday.

While the risk to the public is still low, upfront investments and pandemic preparedness are critical, he said. “If we institute the countermeasures now, and reduce the spread of the virus … we’re much less likely to see a mutation that jumps to humans for which we’re ill-prepared.”

Upon first learning about the outbreak, the FDA developed a program to test milk to ensure it was safe to drink, recognizing the strong likelihood that more dairy cattle herds had...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
FDA approves Amgen drug for tough-to-treat form of lung cancer
US Pharma and Biotech Summit 2024: When FDA Needs to Regulate AI
FDA Approves Tarlatamab-dlle for Extensive-Stage Small Cell Lung Cancer
FDA OKs 1st T-cell therapy for persistent type of lung cancer
Amgen Drug for Aggressive Type of Lung Cancer Wins Accelerated FDA Approval

Share This Article